Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema

MLA

Kiss S, et al. “Clinical Utilization of Anti-Vascular Endothelial Growth-Factor Agents and Patient Monitoring in Retinal Vein Occlusion and Diabetic Macular Edema.” Clinical Ophthalmology, vol. 2014, no. default, Aug. 2014, pp. 1611–21. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.62e4a2bd7544478297994e9de3b98974&authtype=sso&custid=ns315887.

APA

Kiss S, Liu Y, Brown J, Holekamp NM, Almony A, Campbell J, & Kowalski JW. (2014). Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema. Clinical Ophthalmology, 2014(default), 1611–1621.

Chicago

Kiss S, Liu Y, Brown J, Holekamp NM, Almony A, Campbell J, and Kowalski JW. 2014. “Clinical Utilization of Anti-Vascular Endothelial Growth-Factor Agents and Patient Monitoring in Retinal Vein Occlusion and Diabetic Macular Edema.” Clinical Ophthalmology 2014 (default): 1611–21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.62e4a2bd7544478297994e9de3b98974&authtype=sso&custid=ns315887.